Portfolio company
Slingshot Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops and advances early-stage academic drug discovery programmes into clinical-ready biotech assets for the healthcare and pharmaceutical industries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Scorpion Therapeutics
This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.
Pheon Therapeutics
The company develops antibody-drug conjugates to treat solid tumours for the healthcare and pharmaceutical sectors.
Hawkhill Therapeutics
This company develops oral small molecule therapies for obesity and metabolic health to preserve muscle mass for the biotechnology and pharmaceutical sectors.
Theolytics
The company develops oncolytic viral immunotherapies for patients with solid tumours.
Amphista Therapeutics
This company develops targeted protein degradation medicines to treat patients with cancer and other diseases.
ProteoValent Therapeutics
This company develops targeted protein degrader therapies for cancer and haematology patients.
BiovelocITA
This biotech accelerator provides investment and venture-building services to research organisations and early-stage startups to develop therapeutic programmes into commercially viable healthcare companies.
Disruptive Pharma
This company develops a drug formulation platform to improve the solubility and bioavailability of pharmaceutical compounds for the healthcare industry.